Executive Director, Global Business Development, Transactions

Overview

At Daiichi Sankyo, we are united by a single purpose, to improve lives around the world through innovative medicines. With a legacy of innovation since 1899, a presence in more than 30 countries, and more than 19,000 employees, we are advancing breakthrough therapies in oncology, cardiovascular disease, rare diseases, and immune disorders. Guided by our 2030 vision to be an innovative global healthcare company contributing to the sustainable development of society, we are shaping a healthier, more hopeful future for patients, their families, and society.

• Execute assigned transactions through proposal, review, and negotiation of NBAs and Definitive Agreements, acting as Lead for opportunities as assigned by the Vice President of Global Business Development.
• Collaborate with key
  
  Functional Area
  
  Leads (R&D Finance, R&D Global Project Team Leader, Business Development, Legal, and others) and Senior Management to secure alignment on key terms prior to and during active negotiations.
• Communicate activities across the organization through related internal approval committees, sharing key contract terms and the strategic, financial, scientific, and commercial rationale for each opportunity.
• Respond to inquiries from Corporate Finance, Tokyo Business Development, Oncology, R&D, and other stakeholders; engage with other pharmaceutical licensing groups; conduct proactive product searches; coordinate search efforts to identify opportunities to enhance the pipeline; summarize conclusions and recommendations for senior management.
• Schedule and lead due diligence meetings with potential partners; provide strategic alliance management to monitor compliance and address issues; train and develop junior staff.
• Lead deal teams, coordinate with commercial, R&D, finance, supply chain, IP, legal, and other functions across geographies; oversee diligence and present recommendations to senior management.

• MBA with a strong finance focus preferred;
  Master’s Degree considered;
  PhD, MD, or JD acceptable if accompanied by proven leadership in large transactions. Bachelor’s Degree required.

• 10+ years in the pharmaceutical industry with prior Big Pharma experience; track record in leading complex Oncology-focused negotiations to closing; independent transaction leadership and deal-sheets required.
• Experience leading Co-development/Co-commercialization agreements, joint ventures, clinical trial agreements, divestitures, in-/out-licensing, acquisitions, and venture investments; ability to influence internal and external stakeholders.
• Branded Oncology transactions experience; companion diagnostic contracting expertise strongly preferred; matrix leadership experience preferred.
• Travel willingness up to 30% (domestic and some global).

• Ability to travel up to 30% of the time. Frequent overnight travel as required by the deal process; domestic; some global.

• Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.